Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -0.288 | 1.973 | 14.838 | 45.672 | -0.209 | 4.296 | -3.239 | 6.73 |
| Return on Equity (%) | -0.507 | 3.389 | 29.837 | 94.764 | -0.404 | 7.466 | -4.703 | 8.034 |
| Return on Invested Capital (%) | 17.456 | 13.091 | 27.972 | -7.776 | 4.95 | 11.952 | 0.029 | 6.842 |
| Operating Margin (%) | 18.48 | 48.639 | 88.13 | 692.027 | 9.056 | 24.149 | 19.267 | 48.979 |
| Net Profit Margin (%) | -1.501 | 8.899 | 56.997 | 523.189 | -1.601 | 20.618 | -17 | 39.717 |
| Book Value Per Share | 1.844 | 3.107 | 10.739 | 26.242 | -5.376 | 4.7 | 8.21 | 13.228 |
| Earnings Per Share | -0.078 | 0.594 | 6.902 | 37.407 | -0.186 | 3.408 | -1.968 | 2.991 |
| Cash Per Share | 0.897 | 0.975 | 5.642 | 4.253 | 2.961 | 1.164 | 2.655 | 1.316 |
| Working Capital Per Share | -3.065 | -0.087 | 37.961 | 65.782 | 24.903 | 25.233 | 9.722 | 12.655 |
| Operating Profit Per Share | 4.955 | 6.437 | 11.847 | 6.565 | 9.813 | 15.295 | 8.685 | 7.093 |
| EBIT Per Share | 0.381 | 2.706 | 8.347 | 47.354 | -0.655 | 2.821 | 2.124 | 3.651 |
| EBITDA Per Share | 0.381 | 2.706 | 8.347 | 47.354 | -0.655 | 2.821 | 2.124 | 3.651 |
| Free Cash Flow Per Share | 0.338 | 0.104 | 6.622 | 34.959 | -1.62 | 0.885 | -3.155 | 3.985 |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 20.91M | 21.15M | 20.77M | 16.82M | 16.08M | 16.77M | 16.95M | N/A |
| Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Shares Outstanding | 16.95M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | 126.824 | N/A | N/A | N/A | 366.673 | N/A | N/A |
| Net Profit Margin (%) | N/A | 95.384 | N/A | N/A | N/A | 278.065 | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 2.05B |
| Price to Earnings Ratio | 39.92 |
| Price to Sales Ratio | 15.85 |
| Price to Cash Ratio | 90.7 |
| Price to Book Ratio | 2.97 |
| Dividend Yield | - |
| Shares Outstanding | 18.9M |
| Average Volume (1 week) | 98.7k |
| Average Volume (1 Month) | 128.98k |
| 52 Week Change | 53.44% |
| 52 Week High | 129.90 |
| 52 Week Low | 67.53 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
